JUPITER trial

Results: 13



#Item
1BMJ 2013;347:f6123 doi: bmj.f6123 (Published 22 OctoberPage 1 of 5 Analysis

BMJ 2013;347:f6123 doi: bmj.f6123 (Published 22 OctoberPage 1 of 5 Analysis

Add to Reading List

Source URL: press.psprings.co.uk

Language: English - Date: 2014-05-14 11:34:36
2Safety and life-saving efficacy of statins have been exaggerated, says USF scientist

Safety and life-saving efficacy of statins have been exaggerated, says USF scientist

Add to Reading List

Source URL: medicalxpress.com

Language: English - Date: 2015-04-17 03:32:33
3FOR IMMEDIATE RELEASE Contact: Heather Robbins[removed]removed]  S. RAYMOND GOLISH, MD, PhD, APPOINTED AS JUPITER MEDICAL CENTER’S

FOR IMMEDIATE RELEASE Contact: Heather Robbins[removed]removed] S. RAYMOND GOLISH, MD, PhD, APPOINTED AS JUPITER MEDICAL CENTER’S

Add to Reading List

Source URL: cdn.trustedpartner.com

Language: English - Date: 2014-09-19 15:47:13
4FORUM  REVIEW Cardiovascular prevention: Lifestyle and statins – competitors or companions?

FORUM REVIEW Cardiovascular prevention: Lifestyle and statins – competitors or companions?

Add to Reading List

Source URL: www.hypertension.org.za

Language: English - Date: 2014-04-16 04:14:40
5TreatmentUpdate 205  Vol. 26, No. 6 November[removed]Available online at

TreatmentUpdate 205 Vol. 26, No. 6 November[removed]Available online at

Add to Reading List

Source URL: www.catie.ca

Language: English
6Effect of Statins on Venous Thromboembolic Events: A Meta-analysis of Published and Unpublished Evidence from Randomised Controlled Trials Kazem Rahimi1,2,3*, Neeraj Bhala4, Pieter Kamphuisen5, Jonathan Emberson4, Sara B

Effect of Statins on Venous Thromboembolic Events: A Meta-analysis of Published and Unpublished Evidence from Randomised Controlled Trials Kazem Rahimi1,2,3*, Neeraj Bhala4, Pieter Kamphuisen5, Jonathan Emberson4, Sara B

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
7When to Stop a Clinical Trial Early for Benefit: Lessons Learned and Future Approaches Faiez Zannad, Wendy Gattis Stough, John J.V. McMurray, Willem J. Remme, Bertram Pitt, Jeffrey S. Borer, Nancy L. Geller and Stuart J.

When to Stop a Clinical Trial Early for Benefit: Lessons Learned and Future Approaches Faiez Zannad, Wendy Gattis Stough, John J.V. McMurray, Willem J. Remme, Bertram Pitt, Jeffrey S. Borer, Nancy L. Geller and Stuart J.

Add to Reading List

Source URL: www.globalcvctforum.com

Language: English - Date: 2014-10-08 08:34:48
8U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
9COMPARING THE EFFECTIVENESS OF ROSUVASTATIN AND ATORVASTATIN IN PREVENTING CARDIOVASCULAR OUTCOMES: ESTIMATES USING THE ARCHIMEDES MODEL C. Andy Schuetz 1 PhD ,

COMPARING THE EFFECTIVENESS OF ROSUVASTATIN AND ATORVASTATIN IN PREVENTING CARDIOVASCULAR OUTCOMES: ESTIMATES USING THE ARCHIMEDES MODEL C. Andy Schuetz 1 PhD ,

Add to Reading List

Source URL: archimedesmodel.com

Language: English - Date: 2012-01-09 13:06:56
10The following is an internal report which has not been reviewed

The following is an internal report which has not been reviewed

Add to Reading List

Source URL: www.fda.gov

Language: English